Help combat irritable bowel syndrome with probioticsNew York City, N.Y, October 12, 2010 — Recent studies have shown that the use of probiotic supplements can relieve some of the symptoms associated with Irritable Bowel Syndrome by replenishing the gut with the depleted or disturbed bacterial balance. Irritable Bowel Syndrome is caused by an imbalance or lack of the bacterial strain ‘Lactobacillus’ in the intestines and can cause much abdominal discomfort and pain.
Probiotics have been shown to have an overall positive effect on human health including into the problems associated with Irritable Bowel Syndrome and other gastrointestinal problems.
James Betz, founder and CEO of bioceutical firm Biotivia said: “Probiotics are a really important bacteria that we all need to consume but our findings have found that they work even better when prebiotics are also introduced into the diet. We have been working for two years into finding a sustainable way of putting both prebiotics and probiotics together, as they neutralize each other when introduced together, and we came up with Florativia with its unique delivery system.”
Florativia is a synbiotic, a complex of both probiotics and prebiotics in one supplement that work together to improve the “friendly flora” of the human intestine. It was created because a probiotic, without its prebiotic food, does not survive well in the digestive system.
To ensure the the 16 billion healthy probiotics are able to thrive in the intestinal tract, the prebiotics greatly improve the ability of the probiotics to live in the colon and remain viable where it can better eliminate the harmful bacteria.
Betz continues: “With our new synbiotic formula we have created a truly effective health supplement that can help to prevent the suffering associated with irritable bowel syndrome, poor digestive system, depleted gut bacteria from taking antibiotics and those with urinary tract problems. It has also been shown to boost the immune system and to create a healthy gut environment.”
To read more about the benefits of Florativia please visit http://www.biotivia.com/florativia.html
About Biotivia LLC
Biotivia was established in 1992 in Vienna, Austria as a supplier of natural raw materials and botanicals to the supplement and functional food industries and to researchers and scientific institutions worldwide. The company evolved into one of the world’s leading developers and suppliers of potent nutritional supplements and skin care therapies, with most of their products centered around the use of concentrated resveratrol and complementary botanical extracts.
Biotivia presently has US offices in New York, Los Angeles, Kansas City and international offices in the UK, Spain, Austria, Denmark, Italy, Germany, Singapore, Xi’an, China and Mumbai, India.
Beyond its strong consumer base, the company currently supplies researchers, physicians and scientists at Harvard, Stanford, Yale, Georgetown, The Albert Einstein Medical Center, University of Texas, M.D. Anderson Cancer Center and the University of California. Transmax and Bioforte in particular are being explored by several major universities as a possible treatment for a variety of conditions that seriously impair the health and well being of millions of people around the world. Biotivia recently signed an agreement to supply Transmax to the University of Ferrara for use in three human clinical trials in Italy and Egypt on its possible use by Thalassemia sufferers.
Biotivia’s resveratrol products, Transmax and Bioforte, have been independently assessed by Consumer Labs, the leading American quality watchdog, and were deemed both ‘most potent’ and ‘best value’.
Most of Biotivia’s other supplements have been certified Vegan by the American Vegetarian Association.
Neither Florativia nor any Biotivia product has been shown to prevent irritable bowel syndrome. Florativia is not intended to diagnose, prevent, treat or cure any disease. The statements herein have not been reviewed or approved by the US FDA. All Biotivia supplements are manufactured in state of the art FDA inspected pharmaceutical facilities in accordance with CGMP USP standards.
Other press releases from Biotivia Bioceuticals LLC
- Anti-diabetic potential of resveratrol shown in study - September 2nd, 2011
- Biotivia Launch New Pterostilbene Supplement Called PteroActiv - August 23rd, 2011
- Resveratrol Could Benefit Type 2 Diabetics - August 23rd, 2011
- PteroActiv, the new pterostilbene supplement from Biotivia - August 16th, 2011
- Bowel Disorders Can Be Eased With Probiotic Supplements - August 16th, 2011
Contact InformationLeo Day
Title: Marketing Consultant
Biotivia Bioceuticals LLC